The Scientific Basis of Tobacco Product Regulation - World Health ...

Contents
WHO Study Group on Tobacco Product Regulation
Preface
1. Advisory note on smokeless tobacco products: health effects,
implications for harm reduction and research
1.1 Purpose
1.2 Background
1.3 Types of smokeless tobacco product
1.4 Health effects
1.5 Regional and global patterns of use
1.6 Reducing harm due to use of smokeless tobacco
1.7 Conclusions
1.8 Recommendations
1.9 Gaps in knowledge and research needs
References
2. Advisory note on ‘fire-safer’ cigarettes: approaches to reduced
ignition propensity
2.1 Purpose
2.2 Background and history
2.3 Regulatory responses
2.3.1 Effectiveness of regulatory measures in populations
2.3.2 Regulatory considerations
2.4 Research needs
2.4.1 Techniques
2.4.2 Testing methods
2.4.3 Surveillance and monitoring
2.4.4 Exposure to emissions and smoking behaviour
2.5 Findings and recommendations
References
Annex 2.1 Model legislation
3. Mandated lowering of toxicants in cigarette smoke:
tobacco-specific nitrosamines and selected other constituents
3.1 Executive summary and recommendations
3.2 Introduction
3.3 Background
3.4 First report on mandated lowering of tobacco-specific
nitrosamines
3.5 Use of mandated lowering of toxicant levels in a product
regulatory strategy
3.5.1 Selection of machine testing method
3.5.2 Sources of data on toxicants
3.5.3 Criteria for selecting toxicants for mandatory lowering
regulation
3.6 Recommended toxicants for reporting and regulation
vii
ix
1
1
2
3
5
7
7
10
12
12
15
17
17
17
20
23
24
27
27
27
28
28
29
30
33
45
45
48
52
53
57
61
66
66
78
iii